𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Prognostic significance of the hepatoscintigram in patients with chronic liver diseases

✍ Scribed by Taniguchi, T. ;Nishiyama, S. ;Kojima, G. ;Shimizu, Y. ;Kawata,

Publisher
Springer-Verlag
Year
1973
Tongue
English
Weight
66 KB
Volume
8
Category
Article
ISSN
0435-1339

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Carnitine metabolism in patients with ch
Carnitine metabolism in patients with chronic liver disease
✍ S. KrΓ€henbΓΌhl; J. Reichen πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 203 KB πŸ‘ 2 views

with consequent organ dysfunction. Carnitine metabolism Carnitine metabolism was studied in 79 patients with could be disturbed by a variety of mechanisms in patients chronic liver disease, including 22 patients with noncirwith chronic liver disease. Dietary intake of carnitine could rhotic liver di

Pharmacokinetics of isradipine in patien
Pharmacokinetics of isradipine in patients with chronic liver disease
✍ J. Cotting; J. Reichen; K. Kutz; R. Laplanche; E. NΓΌesch πŸ“‚ Article πŸ“… 1990 πŸ› Springer 🌐 English βš– 523 KB

The pharmacokinetics of the dihydropyridine calcium antagonist isradipine has been examined in 8 healthy volunteers, 7 patients with non-cirrhotic chronic liver disease (CLD), and 8 patients with biopsy-proven cirrhosis (CIR). Isradipine was simultaneously given orally (12C 5 mg) and i.v. (13C 1 mg)